Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000834237-21-003749
Filing Date
2021-01-29
Accepted
2021-01-29 09:56:33
Documents
1

Document Format Files

Seq Description Document Type Size
1 us23284f1057_012921.txt SC 13G/A 11587
  Complete submission text file 0000834237-21-003749.txt   13330
Mailing Address 55 EAST 52ND STREET NEW YORK NY 10055
Business Address 55 EAST 52ND STREET NEW YORK NY 10055 212-810-5300
BlackRock Inc. (Filed by) CIK: 0001364742 (see all company filings)

EIN.: 320174431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6211 Security Brokers, Dealers & Flotation Companies

Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Subject) CIK: 0001501989 (see all company filings)

EIN.: 273521219 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89140 | Film No.: 21568707
SIC: 2834 Pharmaceutical Preparations